The economic cost of advanced liver disease
Health care costs for hepatitis C patients with end-stage liver disease are nearly 2.5 times higher than those in the early stages, according to a Henry Ford Hospital study.
Diseases, Conditions, Syndromes
Nov 07, 2011 |
not rated yet |
0
New research on improved treatment options and screening strategies for Hepatitis C
Studies reporting on the effectiveness of new therapies for chronic Hepatitis C virus are among the clinical science presented at the American College of Gastroenterology's 76th Annual Scientific Meeting, where investigators ...
Diseases, Conditions, Syndromes
Oct 31, 2011 |
not rated yet |
0
European studies on risks of hepatocellular carcinoma
Among known risk factors for hepatocellular cancer, smoking, obesity, and heavy alcohol consumption, along with chronic hepatitis B and C infection, contribute to a large share of the disease burden in Europe, according to ...
Cancer
Oct 21, 2011 |
not rated yet |
1
Hepatitis C patients likely to falter in adherence to treatment regimen over time
Patients being treated for chronic hepatitis C become less likely to take their medications over time, according to a new study from the Perelman School of Medicine at the University of Pennsylvania. Since the study also ...
Diseases, Conditions, Syndromes
Sep 29, 2011 |
not rated yet |
0
Liver cancer incidence lower in patients with nonalcoholic fatty liver disease than hepatitis C
Patients with non-alcoholic fatty liver disease (NAFLD) with advanced fibrosis or cirrhosis have a lower incidence of liver-related complications and hepatocellular carcinoma (HCC) than patients infected with hepatitis C ...
Cancer
Sep 27, 2011 |
not rated yet |
0
How liver kills 'killer cells'
Our livers can fight back against the immune system -- reducing organ rejection but also making us more susceptible to liver disease.
Medical research
Sep 19, 2011 |
not rated yet |
0
|
Danger signal limits Hepatitis C infection
Despite the fact that hepatitis C virus (HCV) persists chronically in about 80 percent of those infected, some liver cells remain free of the virus even after many years. Now Sung Key Jang of Pohang University of Science ...
Diseases, Conditions, Syndromes
Sep 19, 2011 |
not rated yet |
0
Saffron shows promise in preventing liver cancer
New research suggests that saffron provides a significant chemopreventive effect against liver cancer in animal models. When saffron was administered to rats with diethylnitrosamine (DEN)-induced liver cancer an inhibition ...
Cancer
Aug 22, 2011 |
not rated yet |
0
Strengthening fragile immune memories to fight chronic infections
After recovering from the flu or another acute infection, your immune system is ready to react quickly if you run into the same virus again. White blood cells called memory T cells develop during the infection and help the ...
Medical research
Aug 18, 2011 |
not rated yet |
0
|
OR models of hepatitis B prove decisive in treating millions in US, China
With hepatitis B infecting as many as 10% of people of Asian descent, operations researchers collaborated with a liver transplant surgeon to develop mathematical models that verified the cost effectiveness of hepatitis B ...
Diseases, Conditions, Syndromes
Jul 26, 2011 |
5 / 5 (1) |
0
Metabolic syndrome increases risk of both major types of primary liver cancer
Incidence rates of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) have increased in the U.S. This population-based study publishing in the August issue of Hepatology, a journal of the American Associ ...
Cancer
Jul 21, 2011 |
not rated yet |
0
Pinpointing a tell-tale mark of liver cancer
Persistent hepatitis C virus (HCV) infection can lead to chronic hepatitis C and then progress to fatal liver diseases including liver cirrhosis and liver cancer, the third most common cause of cancer-related ...
Genetics
Jul 08, 2011 |
not rated yet |
0
|
Genetic variant linked to development of liver cancer in hepatitis C virus carriers
A genome-wide study by researchers at the RIKEN Center for Genomic Medicine, Hiroshima University Hospital and Sapporo-Kosei General Hospital has identified a genetic variant associated with the development ...
Genetics
Jul 03, 2011 |
4 / 5 (1) |
0
|
Gene variant increases fatty liver risk and fibrosis progression
New research confirms that a variant on the patatin-like phospholipase-3 (PNPLA3) gene increases risk of steatosis and fibrosis progression in patients with chronic hepatitis C virus (HCV). The PNPLA3 single nucleotide polymorphism ...
Genetics
Jun 28, 2011 |
not rated yet |
0
New drug represents breakthrough in treatment of hepatitis C
The drug telaprevir (Incivek) provides a dramatic improvement in the treatment of the most common form of hepatitis C infection, says an international team of investigators led by Dr. Ira M. Jacobson of NewYork-Presbyterian ...
Medications
Jun 22, 2011 |
5 / 5 (1) |
0
|
